HER-096

· Herantis Pharma Plc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HER-096, covering 2025-09-12 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease [Phase 1]